Asset Management One Co. Ltd. Boosts Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

Asset Management One Co. Ltd. grew its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 9.5% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 199,057 shares of the medical research company's stock after buying an additional 17,228 shares during the period. Asset Management One Co. Ltd. owned approximately 0.05% of Thermo Fisher Scientific worth $99,051,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of the stock. Bernard Wealth Management Corp. acquired a new position in shares of Thermo Fisher Scientific during the fourth quarter valued at about $25,000. Pillar Financial Advisors LLC acquired a new position in Thermo Fisher Scientific during the 4th quarter worth approximately $29,000. Ameriflex Group Inc. acquired a new stake in Thermo Fisher Scientific in the fourth quarter valued at approximately $30,000. Noble Wealth Management PBC bought a new stake in shares of Thermo Fisher Scientific during the fourth quarter valued at approximately $35,000. Finally, Cassady Schiller Wealth Management LLC lifted its holdings in shares of Thermo Fisher Scientific by 89.2% in the 4th quarter. Cassady Schiller Wealth Management LLC now owns 70 shares of the medical research company's stock worth $36,000 after purchasing an additional 33 shares in the last quarter. Institutional investors and hedge funds own 89.23% of the company's stock.

Insider Activity

In related news, EVP Gianluca Pettiti sold 300 shares of the firm's stock in a transaction that occurred on Monday, April 28th. The shares were sold at an average price of $429.93, for a total value of $128,979.00. Following the sale, the executive vice president now directly owns 23,167 shares of the company's stock, valued at $9,960,188.31. This trade represents a 1.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 0.33% of the company's stock.

Thermo Fisher Scientific Stock Performance

Shares of NYSE TMO traded up $6.08 during midday trading on Wednesday, hitting $410.45. The company's stock had a trading volume of 3,095,351 shares, compared to its average volume of 1,951,602. The stock has a fifty day moving average price of $410.92 and a 200 day moving average price of $485.85. The firm has a market capitalization of $154.94 billion, a price-to-earnings ratio of 24.07, a P/E/G ratio of 2.11 and a beta of 0.78. Thermo Fisher Scientific Inc. has a one year low of $385.46 and a one year high of $627.88. The company has a current ratio of 1.77, a quick ratio of 1.38 and a debt-to-equity ratio of 0.64.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The medical research company reported $5.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.10 by $0.05. The firm had revenue of $10.36 billion for the quarter, compared to the consensus estimate of $10.23 billion. Thermo Fisher Scientific had a net margin of 15.19% and a return on equity of 17.15%. The company's revenue for the quarter was up .2% on a year-over-year basis. During the same period in the prior year, the firm posted $5.11 earnings per share. On average, research analysts forecast that Thermo Fisher Scientific Inc. will post 23.28 EPS for the current fiscal year.

Thermo Fisher Scientific Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Friday, June 13th will be paid a $0.43 dividend. The ex-dividend date of this dividend is Friday, June 13th. This represents a $1.72 dividend on an annualized basis and a yield of 0.42%. Thermo Fisher Scientific's dividend payout ratio is currently 10.09%.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Scotiabank lowered their price objective on shares of Thermo Fisher Scientific from $650.00 to $605.00 and set a "sector perform" rating on the stock in a report on Friday, April 25th. Barclays dropped their price target on shares of Thermo Fisher Scientific from $475.00 to $450.00 and set an "equal weight" rating on the stock in a research report on Tuesday. Stifel Nicolaus decreased their price objective on Thermo Fisher Scientific from $665.00 to $620.00 and set a "buy" rating for the company in a report on Thursday, April 24th. Wells Fargo & Company dropped their target price on Thermo Fisher Scientific from $580.00 to $570.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Finally, Wall Street Zen raised Thermo Fisher Scientific from a "hold" rating to a "buy" rating in a research report on Wednesday, May 21st. Four equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $604.05.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.